Purchase Order N0025922P0176

The Defense Health Agency (DOD) awarded a $320,542.72 delivery order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY, EUA, 250-TEST. The firm fixed price contract has a period of performance starting on January 20, 2022 through February 18, 2022 and will be performed in Portsmouth, Virginia. Gen-Probe Incorporated will provide its APTIMA SARS-COV-2 ASSAY test kits, which have received Emergency Use Authorization from the U.S. Food and...

The Defense Health Agency (DOD) awarded a $339,005 purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide COVID-19 test kits and supplies. The place of performance is Bethesda, Maryland and the contract period is from January 28, 2022 to February 10, 2022. The pricing structure is firm fixed price. Gen-Probe Incorporated will supply coronavirus disease 2019 test kits and related materials to the Defense Health Agency to support continued testing...

The Defense Health Agency (DOD) awarded a $357,330 firm fixed price purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide 95 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 28 Aptima SARS-CoV-2 control boxes containing 5 positive and 5 negative controls per box, and 20 Fusion specimen lysis tubes containing 100 bags per box. The place of performance is Marlborough, Massachusetts and the period of performance is from January 24, 2022...

This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...

The Defense Health Agency awarded a $745,185 firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. for 94 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 47 Aptima SARS-CoV-2 control boxes with five positive and five negative controls per box, and 235 Fusion specimen lysis tubes in 100 bags per box. The place of performance is in Marlborough, Massachusetts and the period of performance runs from February 17, 2022 through September 30, 2023....

<p>The Defense Health Agency awarded a $402,125 firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales &amp; Service, Inc. Division to provide APTIMA SARS-COV-2 ASSAY, EUA APTIMA CONTROLS, FUSION SPECIMEN LYSIS, AND PANTHER RUN KIT products and services. The place of performance will be in Marlborough, Massachusetts over a period starting July 20, 2022 and ending September 29, 2022 to support the agency's Coronavirus COVID-19 National Interest Action.</p>

This firm fixed-price purchase order was awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of 250 APTIMA SARS-CoV-2 assay test kits, 30 APTIMA SARS-CoV-2 controls, and 76 Fusion specimen lysis tubes. The total potential value of the award is $239,790.00. The purchase order was not set aside and supports the government's Coronavirus COVID-19 response efforts. Gen-Probe Incorporated is a provider of molecular diagnostic testing...

This is a $249,560.00 firm fixed-price purchase order contract awarded by the Defense Health Agency to Gen-Probe Incorporated for the APTIMA SARS-COV-2 ASSAY. The contract has a completion date of May 12, 2022 and was awarded on February 11, 2022. Gen-Probe is a medical diagnostics company that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government. The company has held numerous contracts with defense and civilian agencies...

This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, was issued by the Defense Health Agency. The $552,691.20 firm fixed-price delivery order is for the APTIMA SARS-CoV-2 ASSAY, a COVID-19 testing kit under the Emergency Use Authorization (EUA). The contract has no set-aside designation and is scheduled for completion by September 30, 2022. Gen-Probe Incorporated holds several Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with...

The Department of the Army Medical Command awarded a $2.7 million firm fixed-price purchase order to Gen-Probe Incorporated Gen-Probe Sales &amp; Service, Inc. Division for 250 test kits of the SARS-COV-2 assay per kit. The contract is being funded through the Army's medical research programs focused on responding to the coronavirus COVID-19 pandemic and supporting testing capacity. Performance will occur at the Aberdeen Proving Ground in Maryland through December 2021. No subcontractors or...